Nu Skin Enterprises, Inc.

NUS ·Healthcare, Medical Distribution, United States
Financial Statements › Income Statement
Annual Quarterly

Income Statement

Line Item Jun 2024 Mar 2024 Dec 2023 Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
Revenue $439.1M $417.3M $488.6M $498.8M $500.3M $481.5M $522.3M $537.8M
Cost of Revenue $131.9M $123.2M $136.2M $206.5M $135.5M $133.6M $147.8M $173.5M
Gross Profit $307.2M $294.1M $352.4M $292.3M $364.7M $347.9M $374.5M $364.3M
Gross Margin 70.0% 70.5% 72.1% 58.6% 72.9% 72.3% 71.7% 67.7%
Operating Expenses
Research & Development — — — — — — — —
SG&A Expense $117.9M $124.6M $145.0M $130.9M $137.0M $133.9M $127.7M $138.0M
Operating Income $-125.6M $8.8M $16.1M $-26.4M $42.5M $16.1M $27.5M $-20.3M
Operating Margin -28.6% 2.1% 3.3% -5.3% 8.5% 3.3% 5.3% -3.8%
Interest Expense $6.7M $7.3M $7.4M $7.5M $5.8M $4.9M — —
Pretax Income $-131.6M $1.1M $9.3M $-34.5M $37.1M $14.6M $24.4M $-29.0M
Income Tax Expense $-13.4M $1.6M $2.0M $2.5M $10.2M $3.2M $-32.9M $-3.6M
Net Income $-118.3M $-533.0K $7.3M $-37.0M $26.9M $11.4M $57.2M $-25.4M
Net Margin -26.9% -0.1% 1.5% -7.4% 5.4% 2.4% 11.0% -4.7%
EPS (Basic) $-2.38 $-0.01 $0.14 $-0.74 $0.54 $0.23 $1.16 $-0.51
EPS (Diluted) $-2.38 $-0.01 $0.14 $-0.74 $0.54 $0.23 $1.15 $-0.51
Shares Outstanding (Basic) 49.7M 49.5M 49.7M 49.9M 49.9M 49.6M 50.0M 50.2M
Shares Outstanding (Diluted) 49.7M 49.5M 49.9M 49.9M 50.2M 50.1M 50.5M 50.2M
Dividends Per Share — — — — — — — —
← Newer Page 2 of 6 Older →